Influence of Fast and Slow Imagined Muscle Contractions on Muscle Function or Central Nervous System Properties

October 7, 2024 updated by: Garrett Hester, Kennesaw State University

Does the Speed of Imagined Muscle Contractions Affect Muscle Function and Central Nervous System Excitability?

The goal of this randomized clinical trial is to learn if imagining fast or slow muscle contractions causes different responses for nervous system excitability and muscle function in young, healthy males and females in. The main questions are:

Does imagining fast muscle contractions cause greater nervous system excitability compared to imagining slow muscle contractions?

Does imagining fast muscle contractions increase muscle function compared to imagining slow muscle contractions?

A control condition (rest) will be compared with two intervention conditions: imagining fast and imagining slow conditions, to determine if the fast and slow increase outcomes more than control and if fast has the greatest response.

Participants will:

  • Attend 4 laboratory visits
  • Perform 50 imagined contractions fast or slow, but with no physical movement
  • Physical muscle contractions and non-invasive brain stimulation would be completed before and after each condition.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Participants will complete 4 laboratory visits in a randomized order, including a familiarization session, a control condition, and 2 conditions involving imaginary muscle contractions. During visits involving imaginary muscle contractions, participants will complete 2 sets of 25 repetitions of either fast (i.e., less than 1 second to peak torque increase torque as fast as possible) or slow (i.e., 3 seconds to peak torque) isometric elbow flexions. Before and after each condition, single-pulse transcranial magnetic stimulation will be delivered to the primary motor cortex to measure the amplitude of motor-evoked potentials and the duration of the resulting silent periods in the bicep brachii to quantify changes in corticospinal excitability and inhibition, respectively. Rapid maximal voluntary isometric contractions will be used to measure changes in rate of torque development, peak torque, and rate of muscle activation.

Study Type

Interventional

Enrollment (Estimated)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Georgia
      • Kennesaw, Georgia, United States, 30144
        • Recruiting
        • Kennesaw State University
        • Contact:
        • Contact:
          • Garrett Hester, Ph.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Be between the ages of 18 - 30
  • Healthy (no medical conditions)
  • If female, must be taking the same monophasic oral contraceptive for the past 6 months
  • Have a body mass index between 18.5 - 30 kg/m2
  • Have not performed structured cardiovascular or resistance exercise in past 3 years
  • Be right-handed
  • Not currently taking stimulants, antipsychotic, anxiety, or depression medications
  • Have not suffered an upper extremity musculoskeletal injury within the past year

Exclusion Criteria:

  • If transcranial magnetic stimulation (TMS) is not deemed appropriate depending on your responses to the TMS-specific questionnaire
  • Being ambidextrous
  • Although rare, you will be excluded if discernable muscle activation responses are not possible via TMS

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Participants will rest quietly with eyes closed during the control condition.
Experimental: Fast
Participants will imagine 2 blocks of 25 fast muscle contractions separated by 30 sec
The intervention involved imagining, with no physical movement, of muscle contractions.
Experimental: Slow
Participants will imagine 2 blocks of 25 slow muscle contractions separated by 30 sec
The intervention involved imagining, with no physical movement, of muscle contractions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in rate of torque development as measured by newton-meters per second
Time Frame: Baseline, minute 20
A measure of the capacity to increase muscle torque rapidly as determined by the slope of the torque-time curve
Baseline, minute 20
Change in nervous system excitability as measured by electromyographic waveform aplitude following motor cortex stimulation
Time Frame: Baseline, minute 20
A measure of excitability for the corticospinal tract
Baseline, minute 20

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in isometric bicep strength as measured by newton-meters of torque
Time Frame: Baseline, minute 20
Isometric strength of a muscle
Baseline, minute 20
Change in agonist muscle activation as measured by electromyography amplitude
Time Frame: Baseline, minute 20
A measure of the capacity at which the muscle is activated by the nervous system
Baseline, minute 20
Change in antagonist co-activation as measured by electromyography amplitude
Time Frame: Baseline, minute 20
A measure of the capacity at which the antagonist muscle is activated by the nervous system
Baseline, minute 20
Change in rate of agonist muscle activation as measured by electromyography amplitude
Time Frame: Baseline, minute 20
A measure of how quickly the nervous system activates the muscle
Baseline, minute 20
Change in nervous system inhibition as measured by electromyographic waveform aplitude following motor cortex stimulation
Time Frame: Baseline, minute 20
A measure of inhibition for the corticospinal tract
Baseline, minute 20

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported ability to imagine movements as measured by Movement Imagery Questionnaire-Revised as measured on a scale from 8 to 56
Time Frame: Baseline
Survey that estimates one's capacity to imagine movement. A higher score indicates better imagination.
Baseline
Level of vividness for imagining the imagined contractions as measured by 7-point likert scale as measured from 1 to 7
Time Frame: 20 minutes after baseline
A 7-point likert scale is used to to determine how vivid one's imagination was for the conditions. A higher score indicates greater difficulty imagining the movement.
20 minutes after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2024

Primary Completion (Estimated)

May 1, 2025

Study Completion (Estimated)

May 1, 2025

Study Registration Dates

First Submitted

October 2, 2024

First Submitted That Met QC Criteria

October 3, 2024

First Posted (Actual)

October 4, 2024

Study Record Updates

Last Update Posted (Estimated)

October 9, 2024

Last Update Submitted That Met QC Criteria

October 7, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • MI_KA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Non-identifying IPD will be provided upon a reasonable request.

IPD Sharing Time Frame

Beginning 3 months and ending 5 years after the publication of results

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Imagined muscle contractions

Subscribe